The immune-excluded characteristic of ovarian tumors is usually driven by the modification of TME and the presence of inhibitory cells such as myeloid-derived suppressor cells (MDSCs) that prevent effector CD8+ T cells from infiltrating the tumor islets, even if they exist in the stroma [15,22]. Here, CD8A is linked to neoplasm.